Tina Hatley

2.0k total citations · 1 hit paper
6 papers, 1.5k citations indexed

About

Tina Hatley is a scholar working on Physiology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tina Hatley has authored 6 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Physiology, 2 papers in Pharmacology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tina Hatley's work include Asthma and respiratory diseases (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Drug-Induced Adverse Reactions (2 papers). Tina Hatley is often cited by papers focused on Asthma and respiratory diseases (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Drug-Induced Adverse Reactions (2 papers). Tina Hatley collaborates with scholars based in United States. Tina Hatley's co-authors include Thomas A.E. Platts‐Mills, Shama M. Satinover, Diane R. Gold, David Mauro, Jacob D. Hosen, Beloo Mirakhur, Quynh‐Thu Le, Barbara A. Murphy, Jordan Berlin and Robbert J.C. Slebos and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Journal of Allergy and Clinical Immunology.

In The Last Decade

Tina Hatley

6 papers receiving 1.4k citations

Hit Papers

Cetuximab-Induced Anaphylaxis and IgE Specific for Galact... 2008 2026 2014 2020 2008 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tina Hatley United States 4 400 398 397 373 365 6 1.5k
Eishi Miyazaki Japan 25 182 0.5× 573 1.4× 194 0.5× 25 0.1× 267 0.7× 100 1.6k
Heung‐Bum Oh South Korea 19 68 0.2× 263 0.7× 331 0.8× 68 0.2× 267 0.7× 161 1.3k
Kurt Gebauer Australia 21 173 0.4× 72 0.2× 314 0.8× 60 0.2× 184 0.5× 61 1.6k
David Mesher United Kingdom 26 524 1.3× 228 0.6× 124 0.3× 56 0.2× 527 1.4× 52 3.2k
P. C. Frei Switzerland 18 282 0.7× 109 0.3× 155 0.4× 71 0.2× 94 0.3× 65 1.1k
Bjarte G. Solheim Norway 28 55 0.1× 105 0.3× 910 2.3× 249 0.7× 351 1.0× 80 2.2k
Oral Alpan United States 15 476 1.2× 672 1.7× 586 1.5× 26 0.1× 91 0.2× 29 1.8k
Anna‐Brita Laurell Sweden 23 82 0.2× 101 0.3× 702 1.8× 240 0.6× 236 0.6× 78 1.8k
Anthony Timms United Kingdom 17 103 0.3× 67 0.2× 1.0k 2.5× 139 0.4× 197 0.5× 19 1.8k
Xuejun Chen United States 22 47 0.1× 75 0.2× 588 1.5× 187 0.5× 408 1.1× 61 1.8k

Countries citing papers authored by Tina Hatley

Since Specialization
Citations

This map shows the geographic impact of Tina Hatley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tina Hatley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tina Hatley more than expected).

Fields of papers citing papers by Tina Hatley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tina Hatley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tina Hatley. The network helps show where Tina Hatley may publish in the future.

Co-authorship network of co-authors of Tina Hatley

This figure shows the co-authorship network connecting the top 25 collaborators of Tina Hatley. A scholar is included among the top collaborators of Tina Hatley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tina Hatley. Tina Hatley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Chung, Christine H., Beloo Mirakhur, Emily Chan, et al.. (2008). Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose. New England Journal of Medicine. 358(11). 1109–1117. 1075 indexed citations breakdown →
2.
Mirakhur, Beloo, Cecilia P. Chung, Tina Hatley, et al.. (2008). Anaphylactic Reactions To Cetuximab In Patients With Ige Antibodies To The Xenoantigen Galactose-alpha-1,3-galactose. Journal of Allergy and Clinical Immunology. 121(2). S67–S67. 3 indexed citations
3.
Chung, Christine H., Emily Chan, Jordan Berlin, et al.. (2007). Cetuximab-related hypersensitivity reactions associated with pre-existing cetuximab-specific IgE antibody. Journal of Clinical Oncology. 25(18_suppl). 9097–9097. 3 indexed citations
4.
Heymann, Peter W., Holliday T. Carper, Deborah D. Murphy, et al.. (2004). Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. Journal of Allergy and Clinical Immunology. 114(2). 239–247. 306 indexed citations
5.
Peters, Edward J., et al.. (2003). Sinus computed tomography scan and markers of inflammation in vocal cord dysfunction and asthma. Annals of Allergy Asthma & Immunology. 90(3). 316–322. 24 indexed citations
6.
Carper, Holliday T., Gary P. Rakes, James T. Patrie, et al.. (2003). Experimental rhinovirus challenges in adults with mild asthma: Response to infection in relation to IgE. Journal of Allergy and Clinical Immunology. 111(5). 1008–1016. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026